Navigation Links
Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
Date:12/6/2011

ALISO VIEJO, Calif., Dec. 6, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter and year ended September 30, 2011 after market close on Monday, December 12, 2011. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1-877-558-3407
International callers: +1-706-679-1941
Passcode: 33791527

Webcast information: Visit http://www.avanir.com.

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855 859-2056 for domestic callers, or +1-404 537-3406 for international callers, and entering reservation code 33791527.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
2. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
3. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
5. Avanir Pharmaceuticals to Participate in Two Investor Conferences
6. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
7. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
8. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
9. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
10. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
11. Avanir Pharmaceuticals Provides Update on European Regulatory Filing for NUEDEXTA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... is a revolutionary new product that relieves painful carpal tunnel syndrome ... affects more than 8 million people a year. Women suffer from ... methods of treating CTS are painful surgery, the use of NSAIDs ... ... a clear patch worn on the palm of the hand. It ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... Healthy eating isn’t always easy. Currently, more than 80 percent of ... many Americans overeat refined grains and sugar. This trend may help explain why the obesity ... U.S. are obese. , As a culture, we seem to have food on the brain ...
(Date:7/27/2017)... ... July 27, 2017 , ... The Freedom from Cancer Startup ... around 117 breakthrough inventions from 55 institutions, including the National Institutes of Health ... Biomedical Imaging and Bioengineering), the United States Army, and more than fifty American ...
(Date:7/27/2017)... GREENWOOD VILLAGE, CO (PRWEB) , ... July 27, 2017 , ... ... According to the National Funeral Directors Association, this trend is expected to continue with ... this trend, there is a growing demand for new innovations that enable families to ...
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., knows the ... seen an effective and dignified way to keep leeches in place during therapy," she ... This invention provides an effective way to keep a leech in place on the ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley ... major advancement in drug therapy for patients living with relapsing and primary multiple ... novel B cell targeted therapy that has been proven to significantly reduce signs ...
Breaking Medicine News(10 mins):